GlassScriptPhysician profile
Meghan Bonds
NPI 1477089217
$977.63
in general payments reported to CMS, 2019-2025
11 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $109 · 2021: $115 · 2022: $120 · 2023: $171 · 2024: $156 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $321.56 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $204.88 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $145.50 | 2023-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $75.81 | 2020 | |
| Janssen Pharmaceuticals, INC | $51.51 | 2023 | Invega Trinza, Invega Sustenna, Spravato |
| Abbvie INC. | $47.75 | 2021-2023 | Vraylar |
| Exact Sciences Corporation | $42.46 | 2024-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $34.13 | 2024-2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $24.52 | 2023 | Rexulti |
| Ibsa Pharma INC. | $16.68 | 2025 | Flector, Licart, Tirosint |
| Pfizer INC. | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Bonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.